FI944735A0 - Receptorer för melanocytstimulerande hormon hos däggdjur och anvädning - Google Patents

Receptorer för melanocytstimulerande hormon hos däggdjur och anvädning

Info

Publication number
FI944735A0
FI944735A0 FI944735A FI944735A FI944735A0 FI 944735 A0 FI944735 A0 FI 944735A0 FI 944735 A FI944735 A FI 944735A FI 944735 A FI944735 A FI 944735A FI 944735 A0 FI944735 A0 FI 944735A0
Authority
FI
Finland
Prior art keywords
stimulating hormone
melanocyte stimulating
receptor
msh
cultures
Prior art date
Application number
FI944735A
Other languages
English (en)
Finnish (fi)
Other versions
FI944735A (sv
Inventor
Roger D Cone
Kathleen G Mountjoy
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of FI944735A0 publication Critical patent/FI944735A0/sv
Publication of FI944735A publication Critical patent/FI944735A/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI944735A 1992-04-10 1994-10-07 Receptorer för melanocytstimulerande hormon hos däggdjur och anvädning FI944735A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/866,979 US5532347A (en) 1992-04-10 1992-04-10 DNA encoding α melanocyte stimulating hormone receptor
PCT/US1993/003247 WO1993021316A1 (en) 1992-04-10 1993-04-07 Mammalian melanocyte stimulating hormone receptors and uses

Publications (2)

Publication Number Publication Date
FI944735A0 true FI944735A0 (sv) 1994-10-07
FI944735A FI944735A (sv) 1994-12-02

Family

ID=25348840

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944735A FI944735A (sv) 1992-04-10 1994-10-07 Receptorer för melanocytstimulerande hormon hos däggdjur och anvädning

Country Status (10)

Country Link
US (3) US5532347A (sv)
EP (1) EP0635054B1 (sv)
JP (1) JP3512797B2 (sv)
AT (1) ATE255164T1 (sv)
AU (1) AU686099B2 (sv)
CA (1) CA2133843C (sv)
DE (1) DE69333315T2 (sv)
FI (1) FI944735A (sv)
NO (1) NO316448B1 (sv)
WO (1) WO1993021316A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837521A (en) * 1993-04-08 1998-11-17 State Of Oregon Nucleic acids encoding the γ-MSH receptor MC3-R
US6278038B1 (en) 1992-04-10 2001-08-21 Oregon Health And Science University Mammalian melanocortin receptors and uses
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
US5532347A (en) * 1992-04-10 1996-07-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization DNA encoding α melanocyte stimulating hormone receptor
US6448032B1 (en) 1992-08-21 2002-09-10 Jarl Wikberg Human melanocyte stimulating hormone receptor polypeptide and DNA
FR2713645A1 (fr) * 1993-12-08 1995-06-16 Inst Nat Sante Rech Med Polypeptides à activité de récepteur aux mélanocortines, médicaments les comprenant, séquences codant pour eux, sondes, vecteurs et hôtes les exprimant et application au criblage de médicaments.
US5622860A (en) * 1994-02-17 1997-04-22 The Regents Of The University Of Michigan Genes encoding melanocortin receptors
AU7959598A (en) * 1997-06-13 1998-12-30 Oregon Health Sciences University Mammalian melanocortin receptors and uses
EP1137757A1 (en) 1998-11-09 2001-10-04 Merck & Co., Inc. Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey
EP1129105A4 (en) 1998-11-09 2005-03-30 Merck & Co Inc DNA MOLECULES ENCODING THE MELANOCORTIN RECEPTOR 4 PROTEIN FROM RHESUS
US6716810B1 (en) 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
CA2357036A1 (en) 1998-12-23 2000-07-06 Merck & Co., Inc. Dna molecules encoding splice variants of the human melanocortin 1 receptor protein
JP2004509065A (ja) * 2000-04-28 2004-03-25 ゼンジェン　インコーポレイテッド α−ＭＳＨおよびその誘導体を用いる遺伝子治療システムおよび方法
US6593110B2 (en) * 2000-05-04 2003-07-15 California Institute Of Technology Checkpoint-activating oligonucleotides
FR2810883B1 (fr) 2000-06-28 2006-07-28 Seppic Sa Nouveaux latex inverses autoinversibles sur des esters d'acides gras, compositions cosmetiques, dermocosmetiques, dermopharmaceutiques ou pharmaceutiques en comportant
EP1322954A4 (en) * 2000-09-13 2005-08-03 Eleanor Roosevelt Inst METHOD FOR TREATING INSULIN RESISTANCE IN OVERWEIGHT AND DIABETES
US20030113263A1 (en) * 2001-02-13 2003-06-19 Oregon Health And Sciences University, A Non-Profit Organization Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia
AU2002318168B2 (en) 2002-02-25 2007-12-13 Vaxiion Therapeutics, Llc Minicell compositions and methods
FR2856691B1 (fr) 2003-06-26 2005-08-26 Seppic Sa Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant
FR2861397B1 (fr) 2003-10-22 2006-01-20 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse concentre, procede pour sa preparation et utilisation dans l'industrie
WO2005106484A1 (en) * 2004-04-30 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with melanocortin 1 receptor (mc1r)
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
FR2879607B1 (fr) 2004-12-16 2007-03-30 Seppic Sa Nouveaux latex inverse concentre, procede pour sa preparation, et utilisation dans l'industrie
US20080200408A1 (en) * 2005-09-30 2008-08-21 Mccormack Kenneth Deletion mutants of tetrodotoxin-resistant sodium channel alpha subunit
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
FR2950060B1 (fr) 2009-09-11 2011-10-28 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant
FR2959746B1 (fr) 2010-05-06 2012-06-15 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible, son utilisation comme agent epaississant dans une composition cosmetique
FR2992323B1 (fr) 2012-06-25 2015-07-03 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible exempt de tensioactif, son utilisation comme agent epaississant dans une composition cosmetique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650764A (en) * 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4861719A (en) * 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5532347A (en) 1992-04-10 1996-07-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization DNA encoding α melanocyte stimulating hormone receptor

Also Published As

Publication number Publication date
WO1993021316A1 (en) 1993-10-28
US6268221B1 (en) 2001-07-31
AU686099B2 (en) 1998-02-05
NO316448B1 (no) 2004-01-26
DE69333315T2 (de) 2004-09-30
AU4047793A (en) 1993-11-18
US5532347A (en) 1996-07-02
CA2133843A1 (en) 1993-10-11
EP0635054A1 (en) 1995-01-25
FI944735A (sv) 1994-12-02
JPH07508643A (ja) 1995-09-28
JP3512797B2 (ja) 2004-03-31
DE69333315D1 (de) 2004-01-08
ATE255164T1 (de) 2003-12-15
CA2133843C (en) 2003-02-11
EP0635054B1 (en) 2003-11-26
NO943775L (no) 1994-12-01
NO943775D0 (no) 1994-10-07
US5849871A (en) 1998-12-15

Similar Documents

Publication Publication Date Title
FI944735A0 (sv) Receptorer för melanocytstimulerande hormon hos däggdjur och anvädning
Smith et al. Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A
Conti et al. Role of the epidermal growth factor network in ovarian follicles
Leichtling et al. Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes
Potocnik et al. Hemato-lymphoid in vivo reconstitution potential of subpopulations derived from in vitro differentiated embryonic stem cells
Amsterdam et al. Coordinated regulation of morphological and biochemical differentiation in a steroidogenic cell: the granulosa cell model
DE69024291D1 (de) Rezeptoren für Tumornekrosisfaktor-alpha und -beta
FI932573A0 (fi) Maenniskans dopamin-D4-receptor och anvaendningar daerav
ES2118820T3 (es) Anticuerpos monoclonales para receptores de factores de celulas pluripotentes.
Klaus et al. A re-evaluation of the role of C3 in B-cell activation
Ben-Ze'ev et al. Regulation of cytoskeletal protein organization and expression in human granulosa cells in response to gonadotropin treatment
WO1997037998A3 (en) Neuropeptide y receptor y5 and nucleic acid sequence
Mauduit et al. Interleukin-1α as a potent inhibitor of gonadotropin action in porcine Leydig cells: site (s) of action
WO1994003602A3 (en) A novel human dopamine receptor and its uses
CA2133845A1 (en) Adrenocorticotrophic hormone receptor and uses
Carreño et al. Prolactin stimulates maturation and function of rat thymic dendritic cells
Millar et al. Evolution of gonadotropin-releasing hormone: multiple usage of a peptide
Ribeiro-Carvalho et al. Triiodothyronine modulates extracellular matrix-mediated interactions between thymocytes and thymic microenvironmental cells
Ben‐Ze'ev Application of two‐dimensional gel electrophoresis in the study of cytoskeletal protein regulation during growth activation and differentiation
Lehmann et al. Interleukin 2 is a proliferative signal for B cells from autoimmune mice
Ogata et al. Capacities of a newly established thymic stromal cell clone to express la antigens and to produce interleukin-6, colony-stimulating factor, and thymic stroma-derived T-cell growth factor
Fan et al. Establishment and characterization of a novel untransfected corneal endothelial cell line from New Zealand white rabbits
Natkunam et al. Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6.
DK0494260T3 (da) Receptorer for granulocytkolonistimulerende faktor
US20090053181A1 (en) Modulation of Cells

Legal Events

Date Code Title Description
FD Application lapsed